Cancer Immunology, Immunotherapy Issues Research Articles in November 2021 Edition
October 12, 2021
October 12, 2021
BASEL, Switzerland, Oct. 12 -- Cancer Immunology, Immunotherapy, a peer-reviewed journal that says it advances in the field of tumor immunology, published research articles, including the following topics, in its November 2021 edition:
Reviews:
* Risk factors for adverse events induced by immune checkpoint inhibitors in patients with non-small-cell lung cancer: a systematic review and meta-analysis
Original Articles:
* Safety and antibody imm . . .
Reviews:
* Risk factors for adverse events induced by immune checkpoint inhibitors in patients with non-small-cell lung cancer: a systematic review and meta-analysis
Original Articles:
* Safety and antibody imm . . .